Puk5 Comparison of Life Expectancy, Expected Years of Life Lost and Survival Between Hemodialysis and Peritoneal Dialysis Patients

Tw, Kao; Jw, Huang; Hung, KY; Chang, Yeon Soo; Pc, Chen; Yen, Cheng-An; Ym, Chen; Chu, TS; Wu, Kan; Tsai, Tun-Jen; Kd, Wu; Wang, Jiaan-Der

doi:10.1016/s1098-3015(10)74054-7

Cited by 14 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the risk factors associated with survival, age, diabetes [13,[19][20][21], serum albumin [19], BMI [13], and cardiovascular disease [21] were not consistent with our results. Importantly, age is one of the major factors affecting survival in dialysis patients, which is consistent with our ndings.…”

Section: Discussioncontrasting

confidence: 78%

Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study

Hou

Zhang

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The optimal choice of treatment, with hemodialysis (HD) or peritoneal dialysis (PD), for end-stage renal disease (ESRD) patients, is yet controversial. Only a few studies comparing HD and PD have been conducted in China with the largest number of dialysis patients in the world.Methods: A retrospective cohort study was conducted on ESRD patients who began renal replacement treatment from January 1, 2012 to December 31, 2017 in Guangdong Provincial Hospital of Chinese Medicine. Propensity scoring match was applied to balance the baseline conditions and multivariate Cox regression analysis to compare the mortality between HD and PD patients, and evaluated the correlation between mortality and various baseline characteristics.Results: A total of 436 HD patients and 501 PD patients were included in this study, and PD patients had better survival than HD patients, but the difference was not statistically significant. For younger ESRD patients (≤60-years-old), the overall survival of PD was better than that of HD, but HD was associated with a lower risk of death in older patients (>70-years-old). This difference was still significant after adjustment for a variety of confounding factors. Female gender, age of dialysis initiation, cardiovascular disease, cholesterol, and HD were risk factors of all-cause mortality in the younger subgroup, while PD was risk factors in the older subgroup.Conclusion: Younger ESRD patients may be suitable for PD, and the older ESRD patients for HD.

show abstract

Section: Discussioncontrasting

confidence: 78%

Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study

Hou

Zhang

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The estimation was achieved using the iSQoL software 54 . The accuracy and application of this method have been validated in various studies in cohorts of different illnesses 55 56 57 58 , including dialysis populations 59 60 61 .…”

Section: Methodsmentioning

confidence: 99%

Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score

Chang

Hwang

Hung

et al. 2016

Sci Rep

View full text Add to dashboard Cite

Although treatment for the dialysis population is resource intensive, a cost-effectiveness analysis comparing hemodialysis (HD) and peritoneal dialysis (PD) by matched pairs is still lacking. After matching for clinical characteristics and propensity scores, we identified 4,285 pairs of incident HD and PD patients from a Taiwanese national cohort during 1998–2010. Survival and healthcare expenditure were calculated by data of 14-year follow-up and subsequently extrapolated to lifetime estimates under the assumption of constant excess hazard. We performed a cross-sectional EQ–5D survey on 179 matched pairs of prevalent HD and PD patients of varying dialysis vintages from 12 dialysis units. The product of survival probability and the mean utility value at each time point (dialysis vintage) were summed up throughout lifetime to obtain the quality-adjusted life expectancy (QALE). The results revealed the estimated life expectancy between HD and PD were nearly equal (19.11 versus 19.08 years). The QALE’s were also similar, whereas average lifetime healthcare costs were higher in HD than PD (237,795 versus 204,442 USD) and the cost-effectiveness ratios for PD and HD were 13,681 and 16,643 USD per quality-adjusted life year, respectively. In conclusion, PD is more cost-effective than HD, of which the major determinants were the costs for the dialysis modality and its associated complications.

show abstract

“…This method has been successfully applied to study the life expectancy of various kinds of patients having a relatively long survival (13)(14)(15). The iSQoL software that was used to estimate life expectancy can be freely downloaded from http://www.stat.sinica.edu.tw/jshwang.…”

Section: Estimation Of Life Expectancymentioning

confidence: 99%

Lifetime Costs for Peritoneal Dialysis and Hemodialysis in Patients in Taiwan

et al. 2013

View full text Add to dashboard Cite

Puk5 Comparison of Life Expectancy, Expected Years of Life Lost and Survival Between Hemodialysis and Peritoneal Dialysis Patients

Cited by 14 publications

References 0 publications

Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study

Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study

Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score

Lifetime Costs for Peritoneal Dialysis and Hemodialysis in Patients in Taiwan

Contact Info

Product

Resources

About